WINTON MATTHEW (COO) received a stock award from INOZYME PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/27/2025ACC: 0000950170-25-090868
+14.36K
Net shares
Net buyer
$10.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
14.36K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.36K
Price / share
$0.74
Trade value
$10.62K
% of position
194.3%
6/25/2025
7.39K→21.74K
Total
Net shares
+14.36K
Net value
$10.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2025 | A · Award | +14.36K | $0.74 | $10.62K | 194.3% | 7.39K | 21.74K |
| Total | +14.36K | $10.62K | ||||||
Derivative Transactions0
No derivative transactions reported